ADIAL PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Adial Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2021 to Q1 2023.
  • Adial Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2023 was $180K, a 22.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $180K -$53.3K -22.8% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $194K -$52.2K -21.2% Dec 31, 2022 10-Q 2023-05-12
Q3 2022 $207K -$51.1K -19.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $221K -$50.1K -18.5% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $234K -$49.1K -17.4% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $246K Dec 31, 2021 10-K 2023-03-30
Q3 2021 $259K Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $271K Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $283K Mar 31, 2021 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.